CorNova^® is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures, resulting in improved patient outcomes without added procedure time or patient risk.

The company’s FiberHalo^™ stent deployment catheter will enable the physician to place the stent and measure in-stent lumen area 'real time' during the procedure. The FiberHalo^™ post-dilatation catheter will identify and segmentally re-expand areas of under-expansion and also measure post-dilatation results. And the FiberHalo^™ pre-dilation catheter will be able to predict the potential of mechanical failure that would allow for treatment prior to stent placement.

CorNova is developing the Valecor Platinum^® stent, a bare-metal stent with a pure platinum surface for increased biocompatibility and designed to reduce arterial injury, that has shown superior performance and anti-restenosis properties compared to current bare-metal stents.

CorNova announces CE Mark for the Valecor Platinum Stent Delivery System (June 2009)

CorNova to Present at the Glimpse into the Future: Emerging Drug-Eluting Stents Symposium at EuroPCR 2009 (May 2009)

CorNova, Inc. announces the addition of Andrew T. Jay, D.M.D., M.B.A., to its board of directors (Feb 2009)

CorNova, Inc. announces the expansion of its executive team with the appointment of Robert Gallahue as chief financial officer (Feb 2009)